Le Lézard
Classified in: Health
Subjects: TDS, PLW, FVT

WoundZipper Earns Patent for Magnetic Non-Suture Wound Closure Device


BEVERLY HILLS, Calif., Aug. 21, 2017 /PRNewswire/ -- WoundZipper® is an innovative wound closure device, which incorporates magnets to effectively close wounds. Intended primarily for emergency department use, the device is designed by a board-certified emergency department physician, Dr. Moustafa H. Moustafa.

WoundZipper® employs powerful, flexible magnets encased in a proprietary medical-grade coating, designed to adhere to each side of the wound using a hypoallergenic adhesive. The WoundZipper® can be employed to close wounds in a fraction of the time required using conventional methods. Unlike sutures, staples, and steri strips, WoundZipper® achieves uniform closure along the entire wound to speed healing and reduce scarring. It takes less than a minute to apply, does not require local anesthetic, and is painless.

"What I have witnessed in the emergency department many times is a couple with a small child who has a laceration that is bleeding," Dr. Moustafa said. "The child is upset, the parents are upset, but because it's not life-threatening, staff do not consider it a high priority. This results in frustration for all involved. I designed WoundZipper® to offer an instant solution."

"WoundZipper® makes the process of treating and healing a wound fast and effective and increases medical provider efficiency," Moustafa said. "The magnets are pre-aligned as part of the package unit. This provides instant wound approximation since the magnets are immediately attracted to each other as soon as the removable layer is taken away."

As a new wound closure solution, WoundZipper® has been selected for inclusion in the IncubatED program at the American College of Emergency Physicians (ACEP) conference, Oct. 29-Nov. 1 at the Walter E. Washington Convention Center in Washington D.C. The IncubatED program showcases incubator and/or early-stage healthcare products in the emergency department.

The intellectual property associated with WoundZipper® is available for licensing. Visit www.woundzipper.com or watch this demonstration video: https://www.youtube.com/watch?v=7ttyFIp6wbg

Note: November 8, 2016, the U.S. Patent Office granted United States Patent No. 9,486,217 and on July 4, 2017, Patent No. 9,693,776 B1 for the WoundZipper®tm

The WoundZipper® has not been cleared for commercialization in the United States.

 

WoundZipper® has been developed by an emergency department physician to provide a quick and painless way to close wounds.

SOURCE WoundZipper


These press releases may also interest you

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...

at 02:00
Amwins Global Risks is delighted to announce Classic Cars and Cotswolds, an auction to raise money for the Matthew Wilson Multiple Myeloma Fund at Blood Cancer UK. The online auction opens today and features Ferraris, Aston Martins, a Rolls Royce, a...

at 01:35
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces...



News published on and distributed by: